/Companies

Breethe

Baltimore, US · Founded 2014 · Delaware corporation

Find your way into Breethe

Sign up to see every warm intro you have to Breethe

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Breethe team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

CA
Carl A. CohenPresident

Reported raises · per SEC filings

Form D private placements

$19.2M disclosed across 7 rounds · 2015–2019

▶$8MraisedJul 2019 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl A. CohenDirector
  • Bartley GriffithDirector
  • Steven OrwigExecutive Officer
  • Donald W. FallonExecutive Officer
  • Marshal LinderExecutive Officer, Director
Offering amount
$8M
Amount sold
$8M
Minimum investment
$1
Sales commissions
$120K
Placement agents
INTE SECURITIES LLC
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedOct 2018 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marshal LinderDirector
  • Michael CippelExecutive Officer
  • Carl A. CohenExecutive Officer, Director
  • Bartley GriffithDirector
Offering amount
$5M
Amount sold
$3.5M
Minimum investment
$1
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedDec 2017 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CippelExecutive Officer
  • Carl A. CohenExecutive Officer, Director
  • Marshal LinderDirector
  • Bartley GriffithDirector
Offering amount
$3M
Amount sold
$3M
Minimum investment
$1
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedAug 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl A. CohenExecutive Officer, Director
  • Michael CippelExecutive Officer
  • Marshal LinderDirector
  • Bartley GriffithDirector
Offering amount
$3.6M
Amount sold
$1.1M
Minimum investment
$1
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedAug 2016 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bartley GriffithDirector
  • Carl CohenExecutive Officer, Director
  • Marshal LinderDirector
Offering amount
$3.6M
Amount sold
$2.2M
Minimum investment
$1
First sale
Aug 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$575KraisedSep 2015 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl A. CohenExecutive Officer, Director
Offering amount
$650K
Amount sold
$575K
Minimum investment
$1
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$810KraisedJan 2015 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl A. CohenExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$810K
Minimum investment
$1
First sale
Jan 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Breethe raised?
Breethe has disclosed $19.2M raised across 7 rounds.
Where is Breethe headquartered?
Breethe is headquartered in Baltimore, US.